GoodRx Holdings, Inc. (GDRX)
NASDAQ: GDRX · Real-Time Price · USD
4.120
-0.170 (-3.96%)
At close: Apr 4, 2025, 4:00 PM
4.121
+0.001 (0.03%)
After-hours: Apr 4, 2025, 7:56 PM EDT

GoodRx Holdings Statistics

Total Valuation

GoodRx Holdings has a market cap or net worth of $1.58 billion. The enterprise value is $1.68 billion.

Market Cap 1.58B
Enterprise Value 1.68B

Important Dates

The next estimated earnings date is Thursday, May 8, 2025, before market open.

Earnings Date May 8, 2025
Ex-Dividend Date n/a

Share Statistics

GoodRx Holdings has 383.61 million shares outstanding. The number of shares has decreased by -4.42% in one year.

Current Share Class 106.74M
Shares Outstanding 383.61M
Shares Change (YoY) -4.42%
Shares Change (QoQ) -1.27%
Owned by Insiders (%) 3.28%
Owned by Institutions (%) 16.57%
Float 90.86M

Valuation Ratios

The trailing PE ratio is 103.00 and the forward PE ratio is 24.95. GoodRx Holdings's PEG ratio is 1.64.

PE Ratio 103.00
Forward PE 24.95
PS Ratio 2.01
Forward PS 1.88
PB Ratio 2.18
P/TBV Ratio 11.54
P/FCF Ratio 8.65
P/OCF Ratio 8.59
PEG Ratio 1.64
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 16.83, with an EV/FCF ratio of 9.17.

EV / Earnings 102.23
EV / Sales 2.11
EV / EBITDA 16.83
EV / EBIT 19.44
EV / FCF 9.17

Financial Position

The company has a current ratio of 5.32, with a Debt / Equity ratio of 0.75.

Current Ratio 5.32
Quick Ratio 5.10
Debt / Equity 0.75
Debt / EBITDA 5.05
Debt / FCF 2.97
Interest Coverage 1.63

Financial Efficiency

Return on equity (ROE) is 2.21% and return on invested capital (ROIC) is 3.93%.

Return on Equity (ROE) 2.21%
Return on Assets (ROA) 3.62%
Return on Invested Capital (ROIC) 3.93%
Return on Capital Employed (ROCE) 6.82%
Revenue Per Employee $1.07M
Profits Per Employee $22,209
Employee Count 738
Asset Turnover 0.53
Inventory Turnover n/a

Taxes

In the past 12 months, GoodRx Holdings has paid $15.07 million in taxes.

Income Tax 15.07M
Effective Tax Rate 47.90%

Stock Price Statistics

The stock price has decreased by -38.69% in the last 52 weeks. The beta is 1.26, so GoodRx Holdings's price volatility has been higher than the market average.

Beta (5Y) 1.26
52-Week Price Change -38.69%
50-Day Moving Average 4.72
200-Day Moving Average 6.08
Relative Strength Index (RSI) 34.14
Average Volume (20 Days) 1,635,333

Short Selling Information

The latest short interest is 5.74 million, so 1.50% of the outstanding shares have been sold short.

Short Interest 5.74M
Short Previous Month 6.36M
Short % of Shares Out 1.50%
Short % of Float 6.32%
Short Ratio (days to cover) 2.99

Income Statement

In the last 12 months, GoodRx Holdings had revenue of $792.32 million and earned $16.39 million in profits. Earnings per share was $0.04.

Revenue 792.32M
Gross Profit 744.11M
Operating Income 86.20M
Pretax Income -59.30M
Net Income 16.39M
EBITDA 99.54M
EBIT 86.20M
Earnings Per Share (EPS) $0.04
Full Income Statement

Balance Sheet

The company has $448.35 million in cash and $543.39 million in debt, giving a net cash position of -$95.04 million or -$0.25 per share.

Cash & Cash Equivalents 448.35M
Total Debt 543.39M
Net Cash -95.04M
Net Cash Per Share -$0.25
Equity (Book Value) 724.66M
Book Value Per Share 1.89
Working Capital 535.35M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $183.89 million and capital expenditures -$1.24 million, giving a free cash flow of $182.65 million.

Operating Cash Flow 183.89M
Capital Expenditures -1.24M
Free Cash Flow 182.65M
FCF Per Share $0.48
Full Cash Flow Statement

Margins

Gross margin is 93.91%, with operating and profit margins of 10.88% and 2.07%.

Gross Margin 93.91%
Operating Margin 10.88%
Pretax Margin 3.97%
Profit Margin 2.07%
EBITDA Margin 12.56%
EBIT Margin 10.88%
FCF Margin 23.05%

Dividends & Yields

GoodRx Holdings does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield 4.42%
Shareholder Yield n/a
Earnings Yield 1.04%
FCF Yield 11.56%
Dividend Details

Analyst Forecast

The average price target for GoodRx Holdings is $8.68, which is 110.68% higher than the current price. The consensus rating is "Buy".

Price Target $8.68
Price Target Difference 110.68%
Analyst Consensus Buy
Analyst Count 10
Revenue Growth Forecast (5Y) 7.64%
EPS Growth Forecast (5Y) 88.77%
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

GoodRx Holdings has an Altman Z-Score of 2.16 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 2.16
Piotroski F-Score 7